Oliver Pohl

631 total citations
30 papers, 368 citations indexed

About

Oliver Pohl is a scholar working on Epidemiology, Reproductive Medicine and Obstetrics and Gynecology. According to data from OpenAlex, Oliver Pohl has authored 30 papers receiving a total of 368 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 9 papers in Reproductive Medicine and 8 papers in Obstetrics and Gynecology. Recurrent topics in Oliver Pohl's work include Endometriosis Research and Treatment (9 papers), Uterine Myomas and Treatments (8 papers) and Preterm Birth and Chorioamnionitis (7 papers). Oliver Pohl is often cited by papers focused on Endometriosis Research and Treatment (9 papers), Uterine Myomas and Treatments (8 papers) and Preterm Birth and Chorioamnionitis (7 papers). Oliver Pohl collaborates with scholars based in United Kingdom, Germany and France. Oliver Pohl's co-authors include Jean‐Pierre Gotteland, S. Stoll, Wernér E.G. Müller, K. Scheuer, I. Osterloh, R. Howard Zobrist, André Chollet, Vasso Terzidou, Elke Bestel and Phillip R. Bennett and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Scientific Reports and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Oliver Pohl

29 papers receiving 349 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Oliver Pohl United Kingdom 12 121 110 83 61 43 30 368
Anna Kostrzewska Poland 11 39 0.3× 46 0.4× 66 0.8× 42 0.7× 70 1.6× 34 409
Maohua Lai China 12 149 1.2× 14 0.1× 84 1.0× 20 0.3× 15 0.3× 30 457
Martha F. Gimeno Argentina 12 101 0.8× 29 0.3× 63 0.8× 14 0.2× 12 0.3× 24 481
Benedetta Brundu Italy 8 72 0.6× 32 0.3× 78 0.9× 13 0.2× 4 0.1× 11 440
Xiaofei Zhang China 13 14 0.1× 24 0.2× 106 1.3× 12 0.2× 27 0.6× 37 426
Amanda Baron Campaña Brazil 13 21 0.2× 37 0.3× 60 0.7× 100 1.6× 5 0.1× 19 475
S. Bélisle Canada 13 77 0.6× 60 0.5× 56 0.7× 9 0.1× 16 0.4× 35 377
Nancy M. Lainez United States 9 105 0.9× 13 0.1× 47 0.6× 75 1.2× 6 0.1× 13 369
Prabhakar Singh India 8 65 0.5× 11 0.1× 166 2.0× 15 0.2× 4 0.1× 22 389
Folabomi A. Oladosu United States 9 99 0.8× 22 0.2× 169 2.0× 7 0.1× 4 0.1× 15 360

Countries citing papers authored by Oliver Pohl

Since Specialization
Citations

This map shows the geographic impact of Oliver Pohl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oliver Pohl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oliver Pohl more than expected).

Fields of papers citing papers by Oliver Pohl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oliver Pohl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oliver Pohl. The network helps show where Oliver Pohl may publish in the future.

Co-authorship network of co-authors of Oliver Pohl

This figure shows the co-authorship network connecting the top 25 collaborators of Oliver Pohl. A scholar is included among the top collaborators of Oliver Pohl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oliver Pohl. Oliver Pohl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Erickson, Craig A., Laura Pérez‐Cano, Ernest V. Pedapati, et al.. (2024). Safety, Tolerability, and EEG-Based Target Engagement of STP1 (PDE3,4 Inhibitor and NKCC1 Antagonist) in a Randomized Clinical Trial in a Subgroup of Patients with ASD. Biomedicines. 12(7). 1430–1430. 1 indexed citations
2.
Pohl, Oliver, et al.. (2023). Solving AC Power Flow with Graph Neural Networks under Realistic Constraints. 1–7. 7 indexed citations
3.
Pierzyński, Piotr, Oliver Pohl, Shari Mackens, et al.. (2021). The mechanism of action of oxytocin antagonist nolasiban in ART in healthy female volunteers. Reproductive BioMedicine Online. 43(2). 184–192. 3 indexed citations
4.
Griesinger, Georg, Jacques Donnez, Andrew Humberstone, et al.. (2020). THE EFFECT OF THE ORAL OXYTOCIN ANTAGONIST, NOLASIBAN, ON PREGNANCY RATES IN WOMEN UNDERGOING EMBRYO TRANSFER FOLLOWING IVF. Fertility and Sterility. 114(3). e303–e303. 1 indexed citations
5.
6.
Griesinger, Georg, Christophe Blockeel, Piotr Pierzyński, et al.. (2020). Effect of the oxytocin receptor antagonist nolasiban on pregnancy rates in women undergoing embryo transfer following IVF: analysis of three randomised clinical trials. Human Reproduction. 36(4). 1007–1020. 7 indexed citations
7.
Kim, Sung Hye, Oliver Pohl, André Chollet, et al.. (2019). Oxytocin Receptor Antagonists, Atosiban and Nolasiban, Inhibit Prostaglandin F2α-induced Contractions and Inflammatory Responses in Human Myometrium. Scientific Reports. 9(1). 5792–5792. 26 indexed citations
8.
Pohl, Oliver, André Chollet, Philippe Guillaume, et al.. (2018). OBE022, an Oral and Selective Prostaglandin F2 Receptor Antagonist as an Effective and Safe Modality for the Treatment of Preterm Labor. Journal of Pharmacology and Experimental Therapeutics. 366(2). 349–364. 22 indexed citations
9.
10.
Kim, Sung Hye, Oliver Pohl, André Chollet, et al.. (2017). Differential Effects of Oxytocin Receptor Antagonists, Atosiban and Nolasiban, on Oxytocin Receptor–Mediated Signaling in Human Amnion and Myometrium. Molecular Pharmacology. 91(4). 403–415. 19 indexed citations
11.
Pohl, Oliver, et al.. (2015). Effects of the Oral Oxytocin Receptor Antagonist Tocolytic OBE001 on Reproduction in Rats. Reproductive Sciences. 23(4). 439–447. 3 indexed citations
12.
Pohl, Oliver, R. Howard Zobrist, & Jean‐Pierre Gotteland. (2014). The Clinical Pharmacology and Pharmacokinetics of Ulipristal Acetate for the Treatment of Uterine Fibroids. Reproductive Sciences. 22(4). 476–483. 27 indexed citations
13.
Pohl, Oliver, Elke Bestel, & Jean‐Pierre Gotteland. (2014). Synergistic Effects of E2MATE and Norethindrone Acetate on Steroid Sulfatase Inhibition: A Randomized Phase I Proof-of-Principle Clinical Study in Women of Reproductive Age. Reproductive Sciences. 21(10). 1256–1265. 21 indexed citations
14.
Pohl, Oliver, et al.. (2013). Carcinogenicity and Chronic Rodent Toxicity of the Selective Progesterone Receptor Modulator Ulipristal Acetate. Current Drug Safety. 8(2). 77–97. 4 indexed citations
15.
Pohl, Oliver, Alistair Williams, Christine Bergeron, & Jean‐Pierre Gotteland. (2013). A 39-week oral toxicity study of ulipristal acetate in cynomolgus monkeys. Regulatory Toxicology and Pharmacology. 66(1). 6–12. 6 indexed citations
16.
Pohl, Oliver, Ian H. Osterloh, V. Lecomte, & Jean‐Pierre Gotteland. (2012). Changes in gastric pH and in pharmacokinetics of ulipristal acetate a drug-drug interaction study using the proton pump inhibitor esomeprazole. International Journal of Clinical Pharmacology and Therapeutics. 51(1). 26–33. 18 indexed citations
17.
Stoll, S., K. Scheuer, Oliver Pohl, & Wernér E.G. Müller. (2007). Ginkgo Biloba Extract (EGb 761) Independently Improves Changes in Passive Avoidance Learning and Brain Membrane Fluidity in the Aging Mouse. Pharmacopsychiatry. 29(4). 144–149. 54 indexed citations
18.
Stoll, S., Ulrike Hafner, Oliver Pohl, & Wernér E.G. Müller. (1994). Age-related memory decline and longevity under treatment with selegiline. Life Sciences. 55(25-26). 2155–2163. 24 indexed citations
19.
Pohl, Oliver, et al.. (1967). An Unusual Form of Post-Traumatic Confabulation. The Journal of Trauma: Injury, Infection, and Critical Care. 7(3). 488–488. 1 indexed citations
20.
Pohl, Oliver, et al.. (1966). Panencephalitis Nodosa of Unusual Pathology in an Adult Starting with a Retinal Focus. Stereotactic and Functional Neurosurgery. 28(5). 355–362. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna Kostrzewska Breakdown of academic impact, for papers by Maohua Lai Breakdown of academic impact, for papers by Martha F. Gimeno Breakdown of academic impact, for papers by Benedetta Brundu Breakdown of academic impact, for papers by Xiaofei Zhang Breakdown of academic impact, for papers by Amanda Baron Campaña Breakdown of academic impact, for papers by S. Bélisle Breakdown of academic impact, for papers by Nancy M. Lainez Breakdown of academic impact, for papers by Prabhakar Singh Breakdown of academic impact, for papers by Folabomi A. Oladosu
Rankless by CCL
2026